IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

November 28-29, 2017

29th Annual Piper Jaffray Healthcare Conference

Stephen J. Russell, M.D., Ph.D., Vyriad CEO, presented “Oncolytic Virotherapy: The Next Major Breakthrough in Cancer Treatment” at the 28th Annual Piper Jaffray Healthcare Conference

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com